Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Dexamethasone in Acute Myeloma-Induced Renal Failure
NCT00902915Phase 2Unknown
- Sponsor
- Austrian Forum Against Cancer
- Start
- May 2009
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide in multiple myeloma (MM), sponsored by Austrian Forum Against Cancer. Primary endpoints: Myeloma Response Rate, Renal Response Rate and 2 more. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00902915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902915.